N-5984

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C20H22ClNO5
Molecular Weight	391.845
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@H](CC1=CC=C2O[C@H](COC2=C1)C(O)=O)NC[C@H](O)C3=CC=CC(Cl)=C3

InChI

InChIKey=XSOXUIXLUNBLJA-RNRVQEDPSA-N

InChI=1S/C20H22ClNO5/c1-12(22-10-16(23)14-3-2-4-15(21)9-14)7-13-5-6-17-18(8-13)26-11-19(27-17)20(24)25/h2-6,8-9,12,16,19,22-23H,7,10-11H2,1H3,(H,24,25)/t12-,16+,19-/m1/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

N-5984

Code

English

(R)-6-((R)-2-(((R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)PROPYL)-2,3-DIHYDROBENZO(B)(1,4)DIOXINE-2-CARBOXYLIC ACID

Systematic Name

English

KRP-204

Code

English

N5984

Code

English

1,4-BENZODIOXIN-2-CARBOXYLIC ACID, 6-((2R)-2-(((2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL)AMINO)PROPYL)-2,3-DIHYDRO-, (2R)-

Systematic Name

English

(2R)-6-((2R)-2-(((2R)-2-(3-CHLOROPHENYL)-2-HYDROXY-ETHYL)AMINO)PROPYL)-2,3-DIHYDRO-1,4-BENZODIOXINE-2-CARBOXYLIC ACID

Systematic Name

English

Code System Code Type Description

PUBCHEM

9865284

Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023

PRIMARY

FDA UNII

TV97A9Z8ZT

Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023

PRIMARY

CAS

220475-76-3

Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023

PRIMARY

MANUFACTURER PRODUCT INFORMATION

N-5984

Created by admin on Sat Dec 16 08:23:05 GMT 2023 , Edited by admin on Sat Dec 16 08:23:05 GMT 2023

PRIMARY

Developer: Kyorin Pharmaceutical Nisshin Pharma; Class: Anti-hyperglycaemic, Carboxylic acid, Dioxin, Obesity therapy, Small molecule; Mechanism of Action: Beta 3 adrenergic receptor agonist;Highest Development Phase: Discontinued for Diabetes mellitus, Obesity, Overactive bladder

ACTIVE MOIETY


					TV97A9Z8ZT

N-5984